ADAM9 抗体
(ADAM Metallopeptidase Domain 9 (ADAM9))
This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The protein encoded by this gene interacts with SH3 domain-containing proteins, binds mitotic arrest deficient 2 beta protein, and is also involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. Several alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Jul 2010].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| ADAM9 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| ADAM9 抗体 (AA 475-685) | 人 | 兔 Polyclonal |
|
|
|
| ADAM9 抗体 (AA 475-685) | 人 | 兔 Polyclonal |
|
|
|
| ADAM9 抗体 (N-Term) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| ADAM9 抗体 (AA 36-135) | 人 | 小鼠 Monoclonal |
|
|
|
| ADAM9 抗体 (C-Term) | 人 | 小鼠 Monoclonal |
|
|
|
| ADAM9 抗体 (C-Term) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| Recombinant ADAM9 抗体 | 人 | Humanized Monoclonal |
|
|
|
| ADAM9 抗体 (AA 396-445) | 人, 小鼠, 大鼠, 犬, 豚鼠, 马, 兔, 猴, Bat | 兔 Polyclonal |
|
|
|
| ADAM9 抗体 (AA 400-450) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| ADAM9 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| Recombinant ADAM9 抗体 | 人 | Human Monoclonal |
|
|
|
| ADAM9 抗体 | 人 | 兔 Monoclonal |
|
|
|
| ADAM9 抗体 (AA 29-307) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| ADAM9 抗体 (AA 256-360) (AbBy Fluor® 350) | 人 | 兔 Polyclonal |
|
|
|
| ADAM9 抗体 (AA 256-360) (AbBy Fluor® 488) | 人 | 兔 Polyclonal |
|
|
|
| ADAM9 抗体 (AA 256-360) | 人 | 兔 Polyclonal |
|
|
|
| ADAM9 抗体 (AA 256-360) (AbBy Fluor® 555) | 人 | 兔 Polyclonal |
|
|
|
| ADAM9 抗体 (AA 256-360) (AbBy Fluor® 680) | 人 | 兔 Polyclonal |
|
|
|
| ADAM9 抗体 (AA 256-360) (AbBy Fluor® 750) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
1 reference - 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB17777
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 704-733, C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 475-685
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 475-685
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB17776
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 35-64, N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 3E6
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 36-135
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF/ICC (Immunofluorescence (fixed cells): 有验证图片)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- AFfirm8314
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- ELISA (ELISA: 有验证图片)
- FACS (Flow Cytometry: 所列应用)
- 质量等级
- Research Grade
- 适用
- 人
- 宿主
- Humanized
- 克隆形成能力
- Monoclonal
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IP (Immunoprecipitation: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 400-450
Primary Antibody
- SDS (SDS-PAGE: 有验证图片)
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- BLI (Bio-Layer Interferometry: 所列应用)
- Func (Functional Studies: 所列应用)
- SPR (Surface Plasmon Resonance: 所列应用)
- 适用
- 人
- 宿主
- Human
- 克隆形成能力
- Monoclonal
- 克隆
- Imgc936
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 29-307
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 350
- 抗体亚型
- IgG
- 抗原表位
- AA 256-360
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 488
- 抗体亚型
- IgG
- 抗原表位
- AA 256-360
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 256-360
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 555
- 抗体亚型
- IgG
- 抗原表位
- AA 256-360
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 680
- 抗体亚型
- IgG
- 抗原表位
- AA 256-360
Primary Antibody
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 750
- 抗体亚型
- IgG
- 抗原表位
- AA 256-360
Latest Publications for our ADAM9 抗体
: "A Disintegrin and Metalloproteinase 9 Domain (ADAM9) Is a Major Susceptibility Factor in the Early Stages of Encephalomyocarditis Virus Infection." in: mBio, Vol. 10, Issue 1, (2019) (PubMed).
: "Sorting nexin 9 (SNX9) regulates levels of the transmembrane ADAM9 at the cell surface." in: The Journal of biological chemistry, Vol. 293, Issue 21, pp. 8077-8088, (2018) (PubMed).
: "Deletion of ADAM-9 in HGF/CDK4 mice impairs melanoma development and metastasis." in: Oncogene, Vol. 36, Issue 35, pp. 5058-5067, (2017) (PubMed).
: "ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT." in: Scientific reports, Vol. 7, Issue 1, pp. 15108, (2017) (PubMed).
: "Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9." in: Tumour biology, Vol. 39, Issue 6, pp. 1010428317709128, (2017) (PubMed).
: "The association between laminin and microglial morphology in vitro." in: Scientific reports, Vol. 6, pp. 28580, (2016) (PubMed).
: "Arecoline-induced death of human leukemia K562 cells is associated with surface up-modulation of TNFR2." in: Journal of cellular physiology, Vol. 227, Issue 5, pp. 2240-51, (2012) (PubMed).
: "The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein." in: The Journal of biological chemistry, Vol. 286, Issue 4, pp. 2596-606, (2011) (PubMed).
: "Suppression of ADAM17-mediated Lyn/Akt pathways induces apoptosis of human leukemia U937 cells: Bungarus multicinctus protease inhibitor-like protein-1 uncovers the cytotoxic mechanism." in: The Journal of biological chemistry, Vol. 285, Issue 40, pp. 30506-15, (2010) (PubMed).
: "Accelerated wound repair in ADAM-9 knockout animals." in: The Journal of investigative dermatology, Vol. 130, Issue 8, pp. 2120-30, (2010) (PubMed).
: "Sorting nexin 9 (SNX9) regulates levels of the transmembrane ADAM9 at the cell surface." in: The Journal of biological chemistry, Vol. 293, Issue 21, pp. 8077-8088, (2018) (PubMed).
: "Deletion of ADAM-9 in HGF/CDK4 mice impairs melanoma development and metastasis." in: Oncogene, Vol. 36, Issue 35, pp. 5058-5067, (2017) (PubMed).
: "ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT." in: Scientific reports, Vol. 7, Issue 1, pp. 15108, (2017) (PubMed).
: "Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9." in: Tumour biology, Vol. 39, Issue 6, pp. 1010428317709128, (2017) (PubMed).
: "The association between laminin and microglial morphology in vitro." in: Scientific reports, Vol. 6, pp. 28580, (2016) (PubMed).
: "Arecoline-induced death of human leukemia K562 cells is associated with surface up-modulation of TNFR2." in: Journal of cellular physiology, Vol. 227, Issue 5, pp. 2240-51, (2012) (PubMed).
: "The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein." in: The Journal of biological chemistry, Vol. 286, Issue 4, pp. 2596-606, (2011) (PubMed).
: "Suppression of ADAM17-mediated Lyn/Akt pathways induces apoptosis of human leukemia U937 cells: Bungarus multicinctus protease inhibitor-like protein-1 uncovers the cytotoxic mechanism." in: The Journal of biological chemistry, Vol. 285, Issue 40, pp. 30506-15, (2010) (PubMed).
: "Accelerated wound repair in ADAM-9 knockout animals." in: The Journal of investigative dermatology, Vol. 130, Issue 8, pp. 2120-30, (2010) (PubMed).
Aliases for ADAM9 抗体
ADAM metallopeptidase domain 9 (ADAM9) 抗体a disintegrin and metallopeptidase domain 9 (meltrin gamma) (Adam9) 抗体
ADAM metallopeptidase domain 9 (Adam9) 抗体
ADAM metallopeptidase domain 9 L homeolog (adam9.L) 抗体
ADAM metallopeptidase domain 9 (adam9) 抗体
Adam9 抗体
ADAM9 抗体
adam9-A 抗体
AU020942 抗体
CORD9 抗体
cord9 抗体
MCMP 抗体
mcmp 抗体
MDC9 抗体
mKIAA0021 抗体
Mltng 抗体
mltng 抗体
zgc:101824 抗体
您还需要查找其他产品吗？
You are here:
